As of April 15, 2025, Virbac SA (VIRP.PA) has a market cap of $2.82 billion USD. According to our data, Virbac SA is ranked No.3445 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 15, 2025 | $2.82 B |
-6.00%
|
Dec 31, 2024 | $3.00 B |
-11.63%
|
Dec 29, 2023 | $3.39 B |
58.43%
|
Dec 30, 2022 | $2.14 B |
-46.10%
|
Dec 31, 2021 | $3.97 B |
78.84%
|
Dec 31, 2020 | $2.22 B |
0.63%
|
Dec 31, 2019 | $2.21 B |
107.82%
|
Dec 31, 2018 | $1.06 B |
-7.85%
|
Dec 29, 2017 | $1.15 B |
-26.14%
|
Dec 30, 2016 | $1.56 B |
-23.13%
|
Dec 30, 2015 | $2.03 B |
25.97%
|
Dec 31, 2014 | $1.61 B |
13.53%
|
Dec 31, 2013 | $1.42 B |
7.60%
|
Dec 28, 2012 | $1.32 B |
23.62%
|
Dec 30, 2011 | $1.07 B |
-4.97%
|
Dec 30, 2010 | $1.12 B |
78.31%
|
Dec 31, 2009 | $0.63 B |
28.06%
|
Dec 31, 2008 | $0.49 B |
-11.89%
|
Dec 31, 2007 | $0.56 B |
48.02%
|
Dec 29, 2006 | $0.38 B |
19.98%
|
Dec 30, 2005 | $0.31 B |
55.11%
|
Dec 31, 2004 | $0.20 B |
-8.48%
|
Dec 31, 2003 | $0.22 B |
6.12%
|
Dec 31, 2002 | $0.21 B |
33.91%
|
Dec 31, 2001 | $0.16 B |
10.05%
|
Dec 29, 2000 | $0.14 B |
40.30%
|
Dec 31, 1999 | $0.10 B |
-7.73%
|
Dec 31, 1998 | $0.11 B |
1.34%
|
Dec 31, 1997 | $0.11 B |
-10.46%
|
Dec 31, 1996 | $0.12 B |
12.70%
|
Dec 29, 1995 | $0.11 B |
19.55%
|
Dec 30, 1994 | $89.39 M |
-44.53%
|
Dec 31, 1993 | $0.16 B |
28.15%
|
Dec 31, 1992 | $0.13 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Zoetis
ZTS
|
$66.56 B |
-0.001 M
|
![]() USA
|
![]() Elanco
ELAN
|
$4.09 B |
0.000 M
|
![]() USA
|
![]() IDEXX Laboratories
IDXX
|
$32.74 B |
0.000 M
|
![]() USA
|
![]() Phibro Animal Health
PAHC
|
$0.68 B |
0.339 B
|
![]() USA
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() PetIQ
PETQ
|
$0.93 B |
0.000 M
|
![]() USA
|
![]() Neogen
NEOG
|
$1.07 B |
-0.000 M
|
![]() USA
|
Market Cap | = | VIRP.PA Stock Price | * | VIRP.PA Shares Outstanding |
= | $336.27 | * | 8.37 M | |
= | $2.82 B |